A. Vautrin

Long lasting control of viral rebound with a new drug ABX464 targeting Rev – mediated viral RNA biogenesis

M. Wainberg, A. Garcel, Noëlie Campos, 2015, Retrovirology.

Analysis of Site‐Specific RNA–Protein Interactions

I. Behm-Ansmant, C. Branlant, A. Vautrin, 2012 .

Both anti-inflammatory and antiviral properties of novel drug candidate ABX464 are mediated by modulation of RNA splicing

L. Manchon, A. Garcel, Noëlie Campos, 2019, Scientific Reports.

Targeting the Long Non-Coding RNA LINC00599-205 splicing by novel candidate drug ABX464 to produce the anti-inflammatory microRNA miR-124

L. Manchon, A. Garcel, Noëlie Campos, 2019, bioRxiv.

Targeting Long Non-Coding RNA splicing by novel candidate drug

Laurent Manchon, Audrey Vautrin, Jamal Tazi, 2019, 2019 IEEE International Conference on Bioinformatics and Biomedicine (BIBM).

Analysis of Exonic Regions Involved in Nuclear Localization, Splicing Activity, and Dimerization of Muscleblind-like-1 Isoforms*

L. Buée, D. Furling, N. Sergeant, 2011, The Journal of Biological Chemistry.

Both anti-inflammatory and antiviral properties of novel drug candidate ABX464 are mediated by modulation of RNA splicing

L. Manchon, A. Garcel, Noëlie Campos, 2019, Scientific Reports.

ABX464 (Obefazimod) Upregulates miR-124 to Reduce Proinflammatory Markers in Inflammatory Bowel Diseases

A. Garcel, Noëlie Campos, D. Scherrer, 2022, Clinical and translational gastroenterology.